, /PRNewswire/ — Accure Acne, Inc.™ (www.accureacne.com), a pioneer in the development of innovative solutions for the treatment of acne, announced today that that members of its senior leadership team will present at the Canaccord Genuity Medtech, Diagnostics, and Digital Health & Services Forum on November 21, 2024 at 9:00 am EST in New York City. The team will include Christopher Carlton, Chairman and Chief Executive Officer, and Vlad Paul-Blanc, Accure’s Chief Commercial Officer. Together, they will present a summary of the successful completion of the initial limited commercial release in the United States, on-going expansion activities in key markets around the world and discuss the recently announced achievement of a new FDA clearance for the long-term treatment of mild-to-severe inflammatory acne vulgaris.
Management will also be available for one-on-one meetings with investors at the conference. Investors who are interested in meeting with the Accure team are encouraged to reach out to their representative at …